Vaccines in adults

Area of Science:

• Gerontology
• Immunology
• Public Health

Background:

• Global adult population is increasing, with those 60+ projected to be 21.1% by 2050.
• Adult vaccination needs consider age, risk factors, and declining immune response (immunosenescence).
• World Health Organization promotes "Vaccination through the life course" for integrated adult immunization programs.

Purpose of the Study:

• To highlight the growing importance of adult vaccination in public health.
• To discuss challenges and recommendations for adult immunization strategies.
• To emphasize vaccines as a key tool for healthy aging.

Main Methods:

• Review of global demographic trends and vaccination recommendations.
• Analysis of age-related immune system changes (immunosenescence).
• Examination of vaccine-preventable diseases in adults and current immunization schedules.

Main Results:

• Influenza and pneumococcal vaccines are critical for the largest adult age groups.
• Recommendations cover a wide range of diseases including diphtheria, tetanus, HPV, and herpes zoster.
• Immunosenescence poses a significant challenge to vaccine efficacy in older adults.

Conclusions:

• Lifelong vaccination is vital for healthy aging and disease prevention in adults.
• Integrating adult vaccination into national programs requires addressing challenges.
• Valuing vaccines as a preventive tool is essential for public health.